Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News DiaSorin set to launch LIAISON SARS-CoV-2 IgG kit for testing COVID-19 LIAISON SARS-CoV-2 IgG kit : DiaSorin said that it has completed studies at the Policlinico San Matteo in… bypharmanewsdailyApril 13, 2020
